Benchmark initiated coverage of Agilon Health (AGL) with a Buy recommendation
Fintel reports that on Oct 20, 2023 Benchmark initiated coverage on Agilon Health (NYSE:AGL) with Buys recommendation. The analyst’s price forecast suggests a 51.44% upside As of October 5, 2023, Agilon Health’s one-year average price target is 29.29. Estimates range from a low of $21.21 to a high of $43.05. The average price target represents …
Benchmark initiated coverage of Agilon Health (AGL) with a Buy recommendation Read More »